Background: Brain arteriovenous malformations (AVMs) are complex vascular lesions. Endovascular treatment results are usually measured by calculating the volume reduction of the lesions. Nevertheless, vascular flow quantification seems a more physiologically accurate way of measuring endovascular results. We evaluated the use of parametric color coding (PCC) with digital subtraction angiography (DSA), in order to determine the feasibility of PCC to detect and measure the impact of AVM endovascular treatment-induced changes using real-time hemodynamic parameters. Methods and results: Supratentorial brain AVM treatment was evaluated in 29 patients over the course of 38 sessions. Using regions of interest (ROIs) at the carotid siphon, arterial feeder, drainage vein and venous sinus, we found significant increase in time to peak (TTP) values at the arterial feeder, drainage vein and venous sinus. We compared TTP in four different embolization volume groups: I (0-25%), II (26-50%), III (51-75%) and IV (76-100%). We found significant differences between groups and a moderate correlation between embolization percentages, as well as an increase in TTP at the main vein ROI; but not in the arterial side or sinus. Conclusions: Brain AVM endovascular treatment results can be quantified in vivo with PCC. PCC is capable of detecting hemodynamic changes after brain AVM endovascular treatment, that may reflect flow drop, and it is correlated with volume embolization.
Introduction
Brain arteriovenous malformations (AVMs) are complex vascular lesions, with abnormal connections between arteries and veins with an intermediate vascular network (Nidus). 1 Current management of AVMs includes endovascular therapy, microvascular resection, radiosurgery or observation. 1, 2 A detailed study of their vascular architecture is important for management planning. Nevertheless, due to its physiopathology and characteristics, flow understanding is essential for pre and post-study and results evaluation.
The gold standard for AVM study continues to be digital subtraction angiography (DSA), although several new non-invasive tools like 4D CTA or 4D MRA, have become available recently, helping practitioners to understand their complex structure and flow. [3] [4] [5] [6] [7] [8] [9] [10] Parametric color coding (PCC) is a technique that allows temporal and in vivo analysis of vascular flow during DSA. A computer process produces a single color-coded image with quantitative data from the temporal course of density that produces contrast media in its pass through a vascular territory (i.e. the brain). 11 This has been used for studying several brain vascular lesions like aneurysms, stenosis, fistulas, AVMs or vasospasm. [12] [13] [14] [15] [16] [17] [18] The objective of this study was to determine the feasibility of PCC to detect and measure the impact of AVM endovascular treatment-induced changes using real-time hemodynamic parameters.
Patients and methods
A retrospective case series study was conducted. We selected patients with brain AVMs admitted to our center, the Instituto de Neurocirugı´a Dr. Asenjo, Santiago, Chile for endovascular treatment from May 2015 to March 2017. Criteria for eligibility included patients who were over 18 years old, with supratentorial and lobar AVMs, ruptured or unruptured and with none or previous endovascular treatment. Patients that had received previous surgery or radiotherapy were excluded. All sessions from each patient were followed up from their beginning to end of embolization.
Procedure and image acquisition
All patients were treated under general anesthesia. We worked on a Siemens Artis Zee Biplane angiography (Siemens AG, Healthcare Sector, Forcheim, Germany). AVM embolization was performed using femoral access, guiding catheters and microcatheters in arterial AVM feeders.
A 6F guiding catheter was positioned in the internal carotid artery. Images were acquired using 15 frames/ second images on flat panel plane B. Manual injection was performed at an estimated rate of 4 ml/s using 8 ml of undiluted contrast material (Iodexanol, Visipaque 270, GE Healthcare, Milwaukee, WI, USA). The images were then transferred to a Leonardo Õ dedicated workstation (Siemens AG, Healthcare Sector, Forcheim, Germany). PCC was calculated by Syngo TM iFlow TM software. The four different regions of interest (ROIs) were selected at: internal carotid siphon, main AVM arterial feeder, main AVM draining vein and draining venous sinus. We measured the time to peak (TTP, in seconds). We used the same ROIs before and after the embolization ( Figure 1 ). All patients were treated by one experienced interventional neuroradiologist (RR). Volume embolization percentages for each session were classified by one experienced senior neuroradiologist in the following categories: group I: 0-25%; group II: 26-50%; group III: 51-75%; group IV 76-100%.
Statistical analysis
We obtained clinical characteristics of all patients. A Shapiro-Wilk W test was performed to evaluate distribution of variables. The difference in TTP preand post-treatment was obtained using a two-sided Wilcoxon test. At level of p 0.005 was considered statistically significant. When comparing TTP changes for each embolization percentage we used analysis of variance Bonferroni. A Spearman test was used to evaluate the relationship between embolization percentages and flow decrease percentages. All data were analyzed using STATA 13.1/SE (StataCorp, TX, USA).
This project was approved by the local Ethical Scientific Committee (Servicio de Salud Metropolitano-Oriente) and from the Instituto de Neurocirugı´a Dr. Asenjo, Chile. Written informed consent was provided by the patient or a legally authorized representative.
Results
We analyzed 38 embolization sessions in 29 patients (15 males and 14 females), with a mean age of 34.9 years old [12.5 standard deviation (SD)]. All AVMs were superficially located, with no deep or infratentorial lesions. The mean AVM size was 4.1 cm (1.2 SD) with a Spetzler-Martin grade of 2 (45%). The most frequently used embolization material was Ethylene Vinil Alcohol (EVOH) (84%) (Onyx -EV3 Irvine California; Squid EmboFlu Gland, Switzerland), followed by N-butyl cyanocrylate (NBCA) and Precipitating Hydrophobic Injectable Liquid (PHIL) (Microvention Terumo, Tustin, CA, USA). We treated 24 (83%) unruptured AVMs with 13/29 (45%) that were previously treated. The median AVM volume embolization was 33% [interquartile range (IQR) 20-33]. One patient presented a symptomatic bleeding complication (2.6%), an intracerebral hematoma that required surgery after treatment (Table 1) .
When we compared pre-and post-treatment TTP, we found significant differences at the feeding artery ROI, main vein and venous sinus. No significant differences were found in TTP at internal carotid siphon ROI ( Table 2) .
We analyzed data by each volume embolization group (I-IV). For each group, we obtained the percentage of TTP drop in the draining vein and at the venous sinus, as a way of determining embolization impact in AVM outflow. There were significant differences in time variations that could reflect flow changes ( Table 3 ). Between groups, there were significant differences when comparing the embolization group IV with groups I and II. When we did the same using the venous sinus values; we found no significant differences as a total or between groups.
There was a moderate and significant correlation between volume embolization percentages and increase in TTP percentages at the vein (r ¼ 0.5159, n ¼ 38, p < 0.01). Low correlation was seen when using TTP differences at the venous sinus (r ¼ 0.2654, n ¼ 26, p > 0.05).
Discussion
Endovascular treatment is a recognized option for AVM treatment, that usually requires several embolization sessions. 1, [19] [20] [21] In daily practice, volume reduction is the main parameter to measure the effects of endovascular treatment in brain AVMs, with null or no objective data about flow impact. 22 Thus, more accuracy and clinical impact should be the focus in flow decrease of this shunting disease. In this direction, several authors have been studying flow in AVMs. Lindergaard et al. used transcranial Doppler to study flow at arterial feeders, demonstrating the feasibility of the technique. 23 In recent years, new non-invasive tools like 4D Flow magnetic resonance imaging (MRI)/Quantitative Magnetic Resonance Angiography (QMRA) have analyzed flow characteristics in brain AVMs. 9, 24 These methods have allowed a more comprehensive study of AVM complex flow patterns. Moreover, two papers have focused on the effects in flow after endovascular treatment or surgery resection of AVMs. 9,10 They were able to detect significant flow changes with reduction of blood velocities after treatment or flow rearrangement secondary to vascular redistributions. 9, 10 In our study, we determined that PCC was able to detect hemodynamic changes after endovascular treatment for brain AVMs that could be related to flow variations. There was a significant increase in TTP after embolization when this was measured at the arterial feeder, main vein and venous sinus. We found no significant changes at internal carotid siphon times, that could be secondary to redistribution changes as showed by Ansari et al. 10 We also tried to assess the correlation of PCC with the degree of percentage of volume embolization. We found that there were significant differences when we grouped embolization volume percentage in four different types, but this was only seen in the direct output: main vein; but not in the venous sinus. This last result, could be explained because the venous sinus continues receiving other AVM compartments' flow, so higher flows from untreated compartments could avoid flow drop (increased TTP) at this point. Moreover, an increase in embolization volume was correlated with higher TTP increase. There was moderate and significant correlation between these two parameters at the main drainage vein, but again we found no correlation at the venous sinus.
Nowadays, with the commercially available software that we used (Syngo TM iFlow TM , Siemens AG, Healthcare Sector, Forcheim, Germany) PCC can be easily calculated from any 2D DSA with fast processing and results, obtaining quantitative data of blood hemodynamic parameters. PCC has been used to evaluate several brain vascular diseases, showing its potential of getting objective flow information of treatment results. 12, 14, 16, 25 In the field of AVMs a similar technique to PCC was described using an optical flow method to analyze the embolization flow effect of one case. 13 Huang et al., were able to determine a significant decrease in flow after embolization of a shunt inside the nidus. Thus, to our knowledge, ours is the first large clinical series assessing the utility of PCC in AVM endovascular treatment.
The small number of patients and measures are one of the limitations of this feasibility study. We were not able to match clinical evolution to flow changes. This could be an interesting parameter to predict evolution or for changing strategies during endovascular treatment in the angio suite. Although we may talk about flow changes in this publication, PCC only measures time changes between points. Certainly, this could be related to flow but it differs from real flow data obtained by other images studies like computed tomography or MRI. Another limitation could be the manual injections that we performed in each study at a rate of 2 ml/s with a total volume of 8 ml.
Although we tried to be as accurate as possible, this could be better achieved using an automatic pump. We will consider changing to pump injections in further studies. Finally, our results confirm the feasibility of PCC to evaluate AVM endovascular treatment results, using parameters that reflects a more pathophysiologic behavior of this disease. This is a step forward to using a more quantitative measure of endovascular results evaluation, instead of the qualitative and subjective volume measure that is frequently used.
Conclusion
Brain AVM endovascular treatment results can be reliably quantified in vivo with PCC. PCC is capable of detecting hemodynamic changes after brain AVM endovascular treatment, that may reflect flow drop, and it is correlated with volume embolization. Further studies should be focused in correlating PCC angiographic hemodynamic changes to clinical evolution or outcome.
